Skip to main content
SpringerLink
Log in

PAID 1.0 in Practice

A Brief Clarification Regarding its Possibilities and Limitations

  • Correspondence
  • Published:
PharmacoEconomics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. van Baal PHM, Wong A, Slobbe LCJ, et al. Standardizing the inclusion of indirect medical costs in economic evaluations. Pharmacoeconomics 2011; 29 (3): 175–87

    Article  PubMed  Google Scholar 

  2. Nyman JA, Jalal HJ. Including indirect medical care costs from survivor years of life in economic evaluations. Pharmacoeconomics 2011; 29 (3): 173–4

    Article  PubMed  Google Scholar 

  3. van Baal PH, Feenstra TL, Polder JJ, et al. Economic evaluation and the postponement of health care costs. Health Econ 2011 Apr; 20 (4): 432–45

    Article  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

PAID 1.0 in Practice. Pharmacoeconomics 29, 545–547 (2011). https://doi.org/10.2165/11585600-000000000-00000

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/11585600-000000000-00000

Keywords

Search

Navigation